These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1971643)

  • 41. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Trends in antibiotic resistance in Medellín and municipalities of the Metropolitan Area between 2007 and 2012: Results of six years of surveillance].
    Maldonado NA; Múnera MI; López JA; Sierra P; Robledo C; Robledo J;
    Biomedica; 2014; 34(3):433-46. PubMed ID: 25504130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Profile of bacterial isolates and antimicrobial susceptibility: Multicenter study using a one-day cut-off].
    Alonso R; Fernández-Aranguiz A; Colom K; Herreras A; Cisterna R
    Rev Esp Quimioter; 2000 Dec; 13(4):384-93. PubMed ID: 11498705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M; Hu Q; Mai J; Lin Z
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of drug resistance of Pseudomonas aeruginosa and use of antibiotics in burn wards during 6 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2014 Feb; 30(1):9-14. PubMed ID: 24684983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa.
    Chen HY; Yuan M; Ibrahim-Elmagboul IB; Livermore DM
    J Antimicrob Chemother; 1995 Apr; 35(4):521-34. PubMed ID: 7628986
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antimicrobial resistance of Gram negative bacilli isolated from tertiary-care hospitals in Colombia].
    Briceño DF; Correa A; Valencia C; Torres JA; Pacheco R; Montealegre MC; Ospina D; Villegas MV;
    Biomedica; 2010; 30(3):371-81. PubMed ID: 21713339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of nosocomial organisms and their resistance patterns in the intensive care unit of the University Hospital of the West Indies, Kingston, Jamaica.
    Nicholson AM; Ledgister S; Williams T; Robinson S; Gayle P; Lindo T; Castle D; Shaw K; Moonah S
    West Indian Med J; 2009 Mar; 58(2):142-8. PubMed ID: 21866600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
    Briscoe D; Rubowitz A; Assia EI
    Orbit; 2005 Jun; 24(2):95-8. PubMed ID: 16191795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone.
    Varotto F; Maria GD; Azzaro R; Bellissima P; Amato R; Fogliani V; Muscianisi G; Vitale S; Girbino G; Andò F; Laganà P; Delia S; Jacoviello C; Maierna G; Pezza A; Covelli I; Magrì M; Napoletano G; Rossi A; Marone P; Sanguinetti C; Pela R; Tedeschi D; Viola B; Cicciarella S; Messina G; Rizza S; Fraschini F
    J Chemother; 2001 Aug; 13(4):413-23. PubMed ID: 11589485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children.
    Madana J; Yolmo D; Kalaiarasi R; Gopalakrishnan S; Sujatha S
    Int J Pediatr Otorhinolaryngol; 2011 Sep; 75(9):1104-8. PubMed ID: 21715027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of antimicrobial consumption on gram-negative bacteria in inpatients receiving antimicrobial resistance therapy from 2008-2013 at a tertiary hospital in Shanghai, China.
    Guo W; He Q; Wang Z; Wei M; Yang Z; Du Y; Wu C; He J
    Am J Infect Control; 2015 Apr; 43(4):358-64. PubMed ID: 25838134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Surveillance of antimicrobial resistance in gram-negative isolates from intensive care units in Turkey: analysis of data from the last 5 years.
    Leblebicioglu H; Gunaydin M; Esen S; Tuncer I; Findik D; Ural O; Saltoslu N; Yaman A; Tasova Y;
    J Chemother; 2002 Apr; 14(2):140-6. PubMed ID: 12017368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New species-related MIC breakpoints for early detection of development of resistance among gram-negative bacteria in Swedish intensive care units.
    Hanberger H; Nilsson LE; Claesson B; Kärnell A; Larsson P; Rylander M; Svensson E; Sörberg M; Sörén L
    J Antimicrob Chemother; 1999 Nov; 44(5):611-9. PubMed ID: 10552977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Susceptibility patterns of bacterial isolates from intensive care and haematology/oncology patients in New Zealand.
    Morris AJ; Bremmer DA; Jones MR; Schousboe MI
    N Z Med J; 1997 May; 110(1044):187-9. PubMed ID: 9201205
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The in-vitro activity of ceftazidime against clinically important pathogens.
    Knothe H; Dette GA
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():33-41. PubMed ID: 19810167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Surveillance of antimicrobial resistance of bacteria isolated from bloodstream infections: data of the French National Observatory for Epidemiology of Bacterial Resistance to Antibiotics (ONERBA), 1998-2003].
    Bertrand X; Costa Y; Pina P
    Med Mal Infect; 2005 Jun; 35(6):329-34. PubMed ID: 16039819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Trends of bacterial resistance phenotypes in high-complexity public and private hospitals in Colombia].
    Villalobos Rodríguez AP; Díaz Ortega MH; Barrero Garzón LI; Rivera Vargas SM; Henríquez Iguarán DE; Villegas Botero MV; Robledo Restrepo CG; Leal Castro AL
    Rev Panam Salud Publica; 2011 Dec; 30(6):627-33. PubMed ID: 22358414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.